Summary

Persistence Market Research has recently published an extensive report on the global primary care Point-of-Care (POC) diagnostics market, offering a detailed analysis of key market dynamics, including growth drivers, trends, opportunities, and challenges. This report provides a comprehensive overview of the market structure and future outlook.

Key Insights:

• Market Size (2024E): USD 16.3 Billion
• Projected Market Value (2031F): USD 25.2 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 6.4%

Primary Care POC Diagnostics Market Overview:

Point-of-care (POC) diagnostics are medical tests conducted near patients, commonly in primary care settings like clinics and physician offices, providing fast and precise results. These diagnostics are vital for personalized treatment plans, offering immediate insights into health metrics such as cholesterol, blood glucose, and infectious diseases. The rising demand for rapid diagnostic tools, the growing prevalence of chronic diseases, and continuous technological advancements are fueling the global primary care POC diagnostics market.

Market Growth Drivers:

The increasing global burden of chronic illnesses, including cardiovascular diseases, diabetes, and infectious diseases, is a key driver of the POC diagnostics market. Chronic conditions require timely management, and POC diagnostics enable quick testing and immediate treatment decisions. Factors like aging populations, changing lifestyles, and sedentary habits are leading to higher incidences of chronic diseases, highlighting the need for accessible and efficient diagnostic tools in primary care settings.

Market Restraints:

One of the major challenges for the POC diagnostics market is navigating stringent regulatory standards regarding the accuracy and reliability of rapid testing technologies. Regulatory agencies such as the U.S. FDA and EMA impose rigorous standards, creating financial and time-related barriers to market entry. Moreover, uncertainties around reimbursement policies for POC diagnostics, especially in regions where these policies do not align with the benefits of decentralized diagnostics, hinder market growth.

Market Opportunities:

Advancements in technology offer promising opportunities for the POC diagnostics market, particularly in areas like data analytics, connectivity, and device miniaturization. The development of portable diagnostic devices enables bedside testing, improving the efficiency of diagnostic processes. Integration with electronic health records (EHRs) enhances patient care by facilitating seamless data transmission. As healthcare shifts toward preventive care, POC diagnostics provide cost-effective and accessible solutions for early disease detection.

Key Questions Addressed in the Report:

• What factors are driving the growing demand for primary care POC diagnostics?
• Which regions are leading in the adoption of POC diagnostics, and what are the key reasons behind this trend?
• How is the rise in chronic diseases shaping the POC diagnostics market?
• What challenges are slowing the growth of the POC diagnostics market?

Competitive Landscape and Business Strategy:

Major players in the primary care POC diagnostics market, such as BD (Becton, Dickinson, and Company), Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers, are focusing on innovation, acquisitions, and research and development to strengthen their product offerings. These companies are expanding their diagnostic platforms to address a range of medical conditions while maintaining compliance with regulatory requirements. Collaborations with healthcare providers and government bodies are helping to accelerate the adoption of POC diagnostics, ensuring smooth integration into clinical workflows.

Key Market Players

• Roche Diagnostics
• BD Biosciences
• Danaher Corporation
• Abbott Laboratories
• Instrumentation Laboratory
• bioMerieux
• Siemens Healthcare
• Quidel Corporation

Primary Care POC Diagnostics Market Research Segmentation

By Product:

• Glucose Testing
• Hb1Ac Testing
• Autoimmune Disease
• Coagulation
• Fertility
• Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

By End User:

• Pharmacy & Retail Clinics
• Physician Office
• Urgent Care Clinics
• Non-practice Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Primary Care POC Diagnostics Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Global Primary Care POC Diagnostics Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Bn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019-2023
3.2.2. Current Market Size Forecast, 2024-2031
3.3. Global Primary Care POC Diagnostics Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
3.3.3.1. Glucose Testing
3.3.3.2. Hb1Ac Testing
3.3.3.3. Autoimmune Disease
3.3.3.4. Coagulation
3.3.3.5. Fertility
3.3.3.6. Infectious Diseases
3.3.3.7. Cardiac Markers
3.3.3.8. Thyroid Stimulating Hormone
3.3.3.9. Hematology
3.3.3.10. Primary Care Systems
3.3.3.11. Decentralized Clinical Chemistry
3.3.3.12. Feces
3.3.3.13. Lipid Testing
3.3.3.14. Cancer Marker
3.3.3.15. Blood Gas/Electrolytes
3.3.3.16. Ambulatory Chemistry
3.3.3.17. Drug Abuse Testing
3.3.3.18. Urinalysis
3.4. Market Attractiveness Analysis: Product
3.5. Global Primary Care POC Diagnostics Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By End User, 2019-2023
3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
3.5.3.1. Pharmacy & Retail Clinics
3.5.3.2. Physician Office
3.5.3.3. Urgent Care Clinics
3.5.3.4. Non-practice Clinics
3.6. Market Attractiveness Analysis: End User
4. Global Primary Care POC Diagnostics Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2024-2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
5.3.1. By Country
5.3.2. By Product
5.3.3. By End User
5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
5.5.1. Glucose Testing
5.5.2. Hb1Ac Testing
5.5.3. Autoimmune Disease
5.5.4. Coagulation
5.5.5. Fertility
5.5.6. Infectious Diseases
5.5.7. Cardiac Markers
5.5.8. Thyroid Stimulating Hormone
5.5.9. Hematology
5.5.10. Primary Care Systems
5.5.11. Decentralized Clinical Chemistry
5.5.12. Feces
5.5.13. Lipid Testing
5.5.14. Cancer Marker
5.5.15. Blood Gas/Electrolytes
5.5.16. Ambulatory Chemistry
5.5.17. Drug Abuse Testing
5.5.18. Urinalysis
5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
5.6.1. Pharmacy & Retail Clinics
5.6.2. Physician Office
5.6.3. Urgent Care Clinics
5.6.4. Non-practice Clinics
5.7. Market Attractiveness Analysis
6. Europe Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
6.3.1. By Country
6.3.2. By Product
6.3.3. By End User
6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
6.5.1. Glucose Testing
6.5.2. Hb1Ac Testing
6.5.3. Autoimmune Disease
6.5.4. Coagulation
6.5.5. Fertility
6.5.6. Infectious Diseases
6.5.7. Cardiac Markers
6.5.8. Thyroid Stimulating Hormone
6.5.9. Hematology
6.5.10. Primary Care Systems
6.5.11. Decentralized Clinical Chemistry
6.5.12. Feces
6.5.13. Lipid Testing
6.5.14. Cancer Marker
6.5.15. Blood Gas/Electrolytes
6.5.16. Ambulatory Chemistry
6.5.17. Drug Abuse Testing
6.5.18. Urinalysis
6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
6.6.1. Pharmacy & Retail Clinics
6.6.2. Physician Office
6.6.3. Urgent Care Clinics
6.6.4. Non-practice Clinics
6.7. Market Attractiveness Analysis
7. East Asia Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
7.3.1. By Country
7.3.2. By Product
7.3.3. By End User
7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
7.5.1. Glucose Testing
7.5.2. Hb1Ac Testing
7.5.3. Autoimmune Disease
7.5.4. Coagulation
7.5.5. Fertility
7.5.6. Infectious Diseases
7.5.7. Cardiac Markers
7.5.8. Thyroid Stimulating Hormone
7.5.9. Hematology
7.5.10. Primary Care Systems
7.5.11. Decentralized Clinical Chemistry
7.5.12. Feces
7.5.13. Lipid Testing
7.5.14. Cancer Marker
7.5.15. Blood Gas/Electrolytes
7.5.16. Ambulatory Chemistry
7.5.17. Drug Abuse Testing
7.5.18. Urinalysis
7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
7.6.1. Pharmacy & Retail Clinics
7.6.2. Physician Office
7.6.3. Urgent Care Clinics
7.6.4. Non-practice Clinics
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
8.5.1. Glucose Testing
8.5.2. Hb1Ac Testing
8.5.3. Autoimmune Disease
8.5.4. Coagulation
8.5.5. Fertility
8.5.6. Infectious Diseases
8.5.7. Cardiac Markers
8.5.8. Thyroid Stimulating Hormone
8.5.9. Hematology
8.5.10. Primary Care Systems
8.5.11. Decentralized Clinical Chemistry
8.5.12. Feces
8.5.13. Lipid Testing
8.5.14. Cancer Marker
8.5.15. Blood Gas/Electrolytes
8.5.16. Ambulatory Chemistry
8.5.17. Drug Abuse Testing
8.5.18. Urinalysis
8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
8.6.1. Pharmacy & Retail Clinics
8.6.2. Physician Office
8.6.3. Urgent Care Clinics
8.6.4. Non-practice Clinics
8.7. Market Attractiveness Analysis
9. Latin America Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
9.5.1. Glucose Testing
9.5.2. Hb1Ac Testing
9.5.3. Autoimmune Disease
9.5.4. Coagulation
9.5.5. Fertility
9.5.6. Infectious Diseases
9.5.7. Cardiac Markers
9.5.8. Thyroid Stimulating Hormone
9.5.9. Hematology
9.5.10. Primary Care Systems
9.5.11. Decentralized Clinical Chemistry
9.5.12. Feces
9.5.13. Lipid Testing
9.5.14. Cancer Marker
9.5.15. Blood Gas/Electrolytes
9.5.16. Ambulatory Chemistry
9.5.17. Drug Abuse Testing
9.5.18. Urinalysis
9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
9.6.1. Pharmacy & Retail Clinics
9.6.2. Physician Office
9.6.3. Urgent Care Clinics
9.6.4. Non-practice Clinics
9.7. Market Attractiveness Analysis
10. Middle East & Africa Global Primary Care POC Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2024-2031
10.5.1. Glucose Testing
10.5.2. Hb1Ac Testing
10.5.3. Autoimmune Disease
10.5.4. Coagulation
10.5.5. Fertility
10.5.6. Infectious Diseases
10.5.7. Cardiac Markers
10.5.8. Thyroid Stimulating Hormone
10.5.9. Hematology
10.5.10. Primary Care Systems
10.5.11. Decentralized Clinical Chemistry
10.5.12. Feces
10.5.13. Lipid Testing
10.5.14. Cancer Marker
10.5.15. Blood Gas/Electrolytes
10.5.16. Ambulatory Chemistry
10.5.17. Drug Abuse Testing
10.5.18. Urinalysis
10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
10.6.1. Pharmacy & Retail Clinics
10.6.2. Physician Office
10.6.3. Urgent Care Clinics
10.6.4. Non-practice Clinics
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2023
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Roche Diagnostics
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. BD Biosciences
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Danaher Corporation
11.3.3.1. \ Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Abbott Laboratories
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Instrumentation Laboratory
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. bioMerieux
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Siemens Healthcare
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Quidel Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations